September 1, 2022

​

Evan Noch was awarded a K08 career development award from the National Institute of Neurological Disorders and Stroke to target cysteine susceptibility in glioblastoma.  This 5-year award will fund Dr. Noch's efforts to define the mechanism of cysteine susceptibility in glioblastoma and to expand his mouse model paradigms to optimize drug delivery and treatment strategies to exploit this cysteine susceptibility in vivo.

​

Read more about this work here.